Document 0300 DOCN M9590300 TI Nosocomial tuberculosis--strategies for prevention. DT 9509 AU Gilbert GL; Centre for Infectious Disease and Microbiology, Westmead; Hospital, NSW. SO Annu Conf Australas Soc HIV Med. 1994 Nov 3-6;6:207 (unnumbered abstract). Unique Identifier : AIDSLINE ASHM6/95291799 AB Nosocomial transmission from patients with open pulmonary tuberculosis (TB) is a recognized risk for health care workers (HCW) and other patients. It is uncommon with effective antituberculous therapy and limited periods of hospitalization. Recent outbreaks of nosocomial TB in the USA have been associated with: delayed diagnosis of TB or of multidrug resistance (MDR); delayed or inadequate treatment; inadequate isolation facilities; premature release from isolation; patients with unrecognized TB in contact with highly susceptible patients e.g. HIV/AIDS or transplant units; poor ventilation in rooms where aerosols are generated e.g. by collection induced sputum or treatment with aerosolized pentamidine. The risk of transmission depends on the bacterial concentrations in sputum, the extent to which respiratory secretions are expelled into the air, ventilation and the susceptibility of contact. It can be reduced by rapid diagnosis and treatment of TB and early recognition of MDR; education of patients to cover their mouths when coughing; nursing patients (if admission to hospital is necessary) in well-ventilated single isolation rooms (with or without negative pressure or ultraviolet light) until the sputum is smear negative; appropriate use of masks. Acid fast staining of sputum is the best rapid method for diagnosis of infectious pulmonary TB; results should be available within 24 hours. Rapid identification by DNA probe and use of the BACTEC radiometric system for susceptibility testing of M.tuberculosis (Mtb) has reduced the time to specific diagnosis. Susceptibility testing using the luciferase reporter phage technique could provide results within 24 hours. Selective PCR to distinguish Mtb from M. avium in smear-positive AIDS patients could reduce unnecessary isolation. Molecular methods for detection of MDR e.g. by PCR and probing for changes in resistance genes (such as katG, inhA, rpoB) may be available for the diagnostic laboratory in future. DE AIDS-Related Opportunistic Infections/*PREVENTION & CONTROL Cross Infection/*PREVENTION & CONTROL *Disease Transmission, Patient-to-Professional Disinfection Human Occupational Diseases/*PREVENTION & CONTROL *Patient Care Team Risk Factors Tuberculosis, Pulmonary/*PREVENTION & CONTROL Ventilation MEETING ABSTRACT SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).